Cargando…

EGFR Induces E2F1-Mediated Corticotroph Tumorigenesis

The epidermal growth factor receptor (EGFR), expressed in adrenocorticotrophic hormone (ACTH)–secreting pituitary adenomas causing Cushing disease, regulates ACTH production and corticotroph proliferation. To elucidate the utility of EGFR as a therapeutic target for Cushing disease, we generated tra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Araki, Takako, Liu, Xiaohai, Kameda, Hiraku, Tone, Yukiko, Fukuoka, Hidenori, Tone, Masahide, Melmed, Shlomo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2017
Materias:	Clinical Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686559/ https://www.ncbi.nlm.nih.gov/pubmed/29264472 http://dx.doi.org/10.1210/js.2016-1053

Ejemplares similares

Two Distinctive POMC Promoters Modify Gene Expression in Cushing Disease
por: Araki, Takako, et al.
Publicado: (2021)

Expression of EGFR in Pituitary Corticotroph Adenomas and Its Relationship With Tumor Behavior
por: Liu, Xiaohai, et al.
Publicado: (2019)

Glucocorticoid Receptors Are Making a Comeback in Corticotroph Tumorigenesis
por: Theodoropoulou, Marily
Publicado: (2021)

The Impact of Multicultural Interfacility Video Case Conference: A Novel Education Model After the COVID Pandemic
por: Araki, Takako, et al.
Publicado: (2023)

ODP358 The effect of multi-cultural inter-facility endocrine video case conferencing – A novel model of education during the COVID pandemic
por: Araki, Takako, et al.
Publicado: (2022)

Potential Role for the RASD1 Glucocorticoid-Responsive Gene in Corticotroph Tumorigenesis
por: Hernández-Ramírez, Laura C, et al.
Publicado: (2021)

Neuromedin B Receptor Antagonist Suppresses Pomc Expression in AtT-20 Cells and Human Corticotroph Adenoma Cells
por: Sekizaki, Tomonori, et al.
Publicado: (2021)

ODP338 Neuromedin B Receptor Antagonist Suppresses ACTH Secretion and Cell Proliferation in Human and Mouse Corticotroph Adenoma
por: Atsumi, Tatsuya, et al.
Publicado: (2022)

Clinical Significance of Radical Surgery in the Treatment of Silent Corticotroph Adenoma
por: Kim, Junhyung, et al.
Publicado: (2019)

MON-469 Pituitary Corticotroph Lesions: Clinical, Biochemical, and Pathological Characterization of Cushing Disease, Silent Corticotroph Adenomas, and Corticotroph Hyperplasia
por: Castlen, Joseph, et al.
Publicado: (2019)

Refractory corticotroph adenomas
por: Sumal, Amit K. S., et al.
Publicado: (2023)

Clinical Correlation to E-cadherin and Granulation Patterns in Corticotroph Tumors
por: Lipe, Kristin A, et al.
Publicado: (2021)

Editorial: Targeted Therapy for Pituitary Adenomas
por: Araki, Takako, et al.
Publicado: (2019)

Aggressive corticotroph tumors and carcinomas
por: Lasolle, Hélène, et al.
Publicado: (2022)

Corticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX Mutations
por: Casar-Borota, Olivera, et al.
Publicado: (2020)

The Role of Genetic and Epigenetic Changes in Pituitary Tumorigenesis
por: FUKUOKA, Hidenori, et al.
Publicado: (2014)

Paraneoplastic isolated adrenocorticotropic hormone deficiency revealed after immune checkpoint inhibitors therapy: new insights into anti-corticotroph antibody
por: Urai, Shin, et al.
Publicado: (2023)

Clinicopathological predictive factors in the early remission of corticotroph pituitary macroadenomas in a tertiary referral centre
por: Witek, Przemysław, et al.
Publicado: (2016)

Pituitary Cachexia Treated with Corticotrophic Hormone
por: Hemphill, R. E.
Publicado: (1946)

A Case of Silent Corticotroph Adenoma
por: Ibekwe, Usonwanne U, et al.
Publicado: (2021)

Sex differences in pituitary corticotroph excitability
por: Duncan, Peter J., et al.
Publicado: (2023)

ODP355 The analysis of tumor infiltrative lymphocytes in corticotroph adenomas and its relation to hormonal status
por: Fukuoka, Hidenoi, et al.
Publicado: (2022)

SUN-442 EGFR/ErbB2 Targeted Therapy for Aggressive Prolactinomas
por: Cooper, Odelia, et al.
Publicado: (2019)

A Bacterial Artificial Chromosome Reporter System for Expression of the Human FOXP3 Gene in Mouse Regulatory T-Cells
por: Tsuda, Masato, et al.
Publicado: (2017)

EGFR-mediated Macrophage Activation Promotes Colitis-associated Tumorigenesis
por: Hardbower, Dana M., et al.
Publicado: (2017)

Cold inducible RNA binding protein upregulation in pituitary corticotroph adenoma induces corticotroph cell proliferation via Erk signaling pathway
por: Jian, Fangfang, et al.
Publicado: (2016)

Recent Understanding and Future Directions of Recurrent Corticotroph Tumors
por: Hinojosa-Amaya, José Miguel, et al.
Publicado: (2021)

The Role of Glucocorticoid Receptor in the Pathophysiology of Pituitary Corticotroph Adenomas
por: Regazzo, Daniela, et al.
Publicado: (2022)

Clinical, Laboratory, and Treatment Profiles of Silent Corticotroph Adenomas That Have Transformed to the Functional Type: A Case Series With a Literature Review
por: Zheng, Guangyao, et al.
Publicado: (2020)

Paediatric cyclical Cushing’s disease due to corticotroph cell hyperplasia
por: Noctor, E., et al.
Publicado: (2015)

Recent advances in understanding corticotroph pituitary tumor initiation and progression
por: Renner, Ulrich, et al.
Publicado: (2018)

Heterogeneity of Calcium Responses to Secretagogues in Corticotrophs From Male Rats
por: Romanò, Nicola, et al.
Publicado: (2017)

Differential Expression of MicroRNAs in Silent and Functioning Corticotroph Tumors
por: García-Martínez, Araceli, et al.
Publicado: (2020)

Nuclear Receptors as Regulators of Pituitary Corticotroph Pro-Opiomelanocortin Transcription
por: Zhang, Dongyun, et al.
Publicado: (2020)

Corticotroph adenoma and pituitary fungal infection: a rare association
por: Catarino, Diana, et al.
Publicado: (2020)

Long-Term Corticotroph Function Following Cure of Cushing’s Syndrome
por: Schernthaner-Reiter, Marie Helene, et al.
Publicado: (2021)

Endoscopic endonasal transcavernous approach for invasive corticotroph pituitary adenoma
por: Lan, Ming-Ying, et al.
Publicado: (2020)

LBODP079 A Case of Silent Invasive Corticotroph Adenoma
por: Bendaram, Snigdha Reddy, et al.
Publicado: (2022)

Prospective Evaluation of Incidental Pituitary Imaging Findings in the Sella Turcica
por: Kuo, Michael, et al.
Publicado: (2020)

Case Report: Progression of a Silent Corticotroph Tumor to an Aggressive Secreting Corticotroph Tumor, Treated by Temozolomide. Changes in the Clinic, the Pathology, and the β-Catenin and α-SMA Expression
por: Demarchi, Gianina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3fm2afqfr0334g2dp8j9cspus7